A New Approach to
with smartphone-powered kidney testing
Download the White Paper
Nearly 1.2 million Medicare Advantage members have undiagnosed chronic kidney disease (CKD), a major cost driver for payers.
Although a simple urine test can provide an early warning for the disease during its early asymptomatic stages, the albumin-to-creatinine ratio (ACR) test rates for at-risk people are as low as 20%.
As a result, many Americans are unaware of the problem and miss the opportunity for earlier, life-saving interventions.
Download this white paper to learn how smartphone-powered, at-home kidney health testing can:
- increase compliance rates for ACR testing
- improve clinical outcomes for patients
- reduce kidney care costs for health plans